Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2024 ∙ Rahim, M. H. A. Dom, S. H. M. Hamzah, M. S. R. Azman, S. H. Zaharuddin, Z. Fahrni, M. L.

Impact of pharmacist interventions on immunisation uptake: a systematic review and meta-analysis

  • All age groups
  • Healthcare workers
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Man, M. A. Rosca, D. Bratosin, F. Fira-Mladinescu, O. Ilie, A. C. Burtic, S. R. Fildan, A. P. Fizedean, C. M. Jianu, A. M. Negrean, R. A. Marc, M. S.

Impact of Pre-Infection COVID-19 Vaccination on the Incidence and Severity of Post-COVID Syndrome: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Wu, Q. Zhang, P. Zhou, G. Fu, Q. Bai, R. Ding, H. Meng, F. Xu, X. Chen, M.

Impact of SARS-CoV-2 Vaccination or Infection on the Safety and Efficacy of Aesthetic Injections: A Systematic Review

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Padhi, B. K. Gupta, P. C. Al Kaabi, N. A. Al-Subaie, M. F. Alrasheed, H. A. Sulaiman, T. Rabaan, A. A. Khatib, M. N. Gaidhane, S. Zahiruddin, Q. S. Dziedzic, A. Satapathy, P. Fraj, N. J. Aldrazi, F. A. Kukreti, N. Rustagi, S. Abu Serhan, H.

Incidence and Association of Uveitis with COVID-19 Vaccination: A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Yazdani, A. Mirmosayyeb, O. Sadeghi, M. Ghoshouni, H. Tavakol, G. Ghajarzadeh, M.

Incidence of Guillain-Barré Syndrome (GBS) after COVID-19 Vaccination: a Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Spencer, J. C. Spees, L. P. Biddell, C. B. Odebunmi, O. O. Ilyasova, A. A. Yanguela, J. Lich, K. H. Mills, S. D. Higgins, C. R. Ozawa, S. Wheeler, S. B.

Inclusion of marginalized populations in HPV vaccine modeling: A systematic review

  • All age groups
  • Human papillomavirus (HPV)
  • Modeling
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Beetch, J. E. Janitz, A. Beebe, L. A. Gowin, M. Xu, C. Clifton, S. Kuhn, K. G.

Indirect Effects of the COVID-19 Pandemic on Routine Childhood Vaccination in Low-Income Countries: A Systematic Review to Set the Scope for Future Pandemics

  • Newborn
  • Children
  • Adolescents
  • Low and Middle Income Countries
  • Tuberculosis
  • Poliomyelitis
  • Diphtheria
  • Pertussis
  • Tetanus
  • Hepatitis B
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Rotavirus
  • Measles
  • Rubella
  • Malaria
  • Yellow fever
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Chavers, T. Cates, J. Burnett, E. Parashar, U. D. Tate, J. E.

Indirect protection from rotavirus vaccines: a systematic review

  • All age groups
  • Rotavirus
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Begum, S. Herrera-Restrepo, O. Rolland, C. Purushotham, S. Andani, A. Shah, H. Kocaata, Z.

Inequalities in the risk and prevention of invasive meningococcal disease in the United States - A systematic literature review

  • Americas
  • United States of America
  • All age groups
  • Meningococcal disease
  • Coverage
  • Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Muchangi, J. M. Mturi, J. Mukasa, H. Kithuki, K. Kosgei, S. J. Kanyangi, L. M. Moraro, R. Kamau, S. Nankanja, M.

Influence of government policies on handwashing and vaccine uptake in Kenya, Uganda, and Tanzania to prevent and control COVID-19: a systematic review

  • Africa
  • Kenya
  • Uganda
  • All age groups
  • COVID-19
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...